Prognostic and survival impact of BCL9 and RPS6KB1 copy number variation detected from circulating free DNA in hepatocellular carcinoma.
Samar Samir YoussefRady Eid El-ArabyEman Abd El-Razek AbbasMohamed HassanyTamer ElbazPublished in: Expert review of molecular diagnostics (2023)
cfDNA was used to detect BCL9 and RPS6KB1 CNVs, which influence prognosis and can be used as independent predictors of HCC patient survival.